1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluating treatment tolerability using the toxicity index with patient-reported outcomes data
    Journal Article

    Langlais, B.; Mazza, G. L.; Thanarajasingam, G.; Rogak, L. J.; Ginos, B.; Heon, N.; Scher, H. I.; Schwab, G.; Ganz, P. A.; Basch, E.; more...
    Journal of Pain and Symptom Management (2022)

    Fulltext@MSK | Save
  • Acupuncture for quality of life in gastric cancer patients undergoing adjuvant chemotherapy
    Journal Article

    Zhu, Y. J.; Wu, X. Y.; Wang, W.; Chang, X. S.; Zhan, D. D.; Diao, D. C.; Xiao, J.; Li, Y.; Ma, D.; Hu, M.; more...
    Journal of Pain and Symptom Management (2022)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab for advanced endometrial cancer
    Journal Article

    Makker, V.; Colombo, N.; Casado Herráez, A.; Santin, A. D.; Colomba, E.; Miller, D. S.; Fujiwara, K.; Pignata, S.; Baron-Hay, S.; Ray-Coquard, I.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Randomized phase III BMT CTN trial of calcineurin inhibitor-free chronic graft-versus-host disease interventions in myeloablative hematopoietic cell transplantation for hematologic malignancies
    Journal Article

    Luznik, L.; Pasquini, M. C.; Logan, B.; Soiffer, R. J.; Wu, J.; Devine, S. M.; Geller, N.; Giralt, S.; Heslop, H. E.; Horowitz, M. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Randomized controlled phase II evaluation of two dose levels of bupropion versus placebo for sexual desire in female cancer survivors: NRG-CC004
    Journal Article

    Barton, D. L.; Pugh, S. L.; Ganz, P. A.; Plaxe, S. C.; Koontz, B. F.; Carter, J.; Greyz-Yusupov, N.; Page, S. J.; Rowland, K. M. Jr; Balcueva, E. P.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Treatment exposure and discontinuation in the PALbociclib CoLlaborative Adjuvant Study of palbociclib with adjuvant endocrine therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)
    Journal Article

    Mayer, E. L.; Fesl, C.; Hlauschek, D.; Garcia-Estevez, L.; Burstein, H. J.; Zdenkowski, N.; Wette, V.; Miller, K. D.; Balic, M.; Mayer, I. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: Clinical outcomes and translational biomarker analyses
    Journal Article

    Friedman, C. F.; Spencer, C.; Cabanski, C. R.; Panageas, K. S.; Wells, D. K.; Ribas, A.; Tawbi, H.; Tsai, K.; Postow, M.; Shoushtari, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: Survival update and new extension cohort data
    Journal Article

    Sehn, L. H.; Hertzberg, M.; Opat, S.; Herrera, A. F.; Assouline, S.; Flowers, C. R.; Kim, T. M.; McMillan, A.; Ozcan, M.; Safar, V.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Registry-based randomized clinical trials in surgery: Working with ACS-NSQIP and the AHPBA to conduct pragmatic trials
    Review

    Ecker, B. L.; Brajcich, B. C.; Ellis, R. J.; Ko, C. Y.; D'Angelica, M. I.
    Journal of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers
    Journal Article

    Yarchoan, M.; Cope, L.; Ruggieri, A. N.; Anders, R. A.; Noonan, A. M.; Goff, L. W.; Goyal, L.; Lacy, J.; Li, D.; Patel, A. K.; more...
    Journal of Clinical Investigation (2021)

    Fulltext@MSK | Save